Systemic vasculitides are heterogeneous disabling diseases characterised by chronic
inflammation of the blood vessels potentially leading to tissue destruction and organ failure …

Simple Summary ANCA-associated vasculitis (AAV) is a rare disease and manifests in
different organs. The exact mechanism of AAV is not fully understood, but it is speculated …

Objective To develop a score assessing the probability of relapse in granulomatosis with
polyangiitis (GPA) and microscopic polyangiitis (MPA). Methods Long-term follow-up data …

In recent years, clinical research has increased significantly and therapies for antineutrophil
cytoplasmic antibody (ANCA)-associated vasculitis have improved. However, there are still …

Objective To compare rituximab‐versus cyclophosphamide‐based remission induction
strategies for the long‐term risks of kidney failure and death in antineutrophil cytoplasmic …

Objective Treatment regimens combining glucocorticoids with cyclophosphamide or
rituximab or both are used to induce remission in ANCA-associated glomerulonephritis …

Abstract Purpose of Review The purpose of this review is to summarize and evaluate most
recent evidence on the epidemiology of infections and associated risk factors in patients with …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been
traditionally treated using glucocorticoids and immunosuppressants. However, these …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of
autoimmune diseases. This study aimed to investigate the clinical significance of changes in …

Antineutrophil cytoplasmic antibody-associated vasculitis Page 1 MNH 330508 CURRENT
OPINION Antineutrophil cytoplasmic antibody-associated vasculitis Raghunandan Konda, Arun …